Comparative efficacy and safety of adjunctive drugs to levodopa for fluctuating Parkinson’s disease - network meta-analysis

It remains unclear which adjunctive drug for Parkinson’s disease (PD) in combination with levodopa is more effective, tolerable, and safe. We aimed to compare the efficacy, tolerability, and safety among anti-PD drugs from several classes in patients with fluctuating PD who received levodopa through...

Descripción completa

Detalles Bibliográficos
Autores principales: Sako, Wataru, Kogo, Yuki, Koebis, Michinori, Kita, Yoshiaki, Yamakage, Hajime, Ishida, Takayuki, Hattori, Nobutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584871/
https://www.ncbi.nlm.nih.gov/pubmed/37853009
http://dx.doi.org/10.1038/s41531-023-00589-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584871/
https://www.ncbi.nlm.nih.gov/pubmed/37853009
http://dx.doi.org/10.1038/s41531-023-00589-8

Ejemplares similares